RE

Ronald M. Evans

SS Salk Institute For Biological Studies: 138 patents #1 of 521Top 1%
LI Ligand Pharmaceuticals Incorporated: 8 patents #21 of 191Top 15%
MI Mitobridge: 8 patents #3 of 40Top 8%
TS The University Of Sydney: 7 patents #11 of 441Top 3%
BM Baylor College Of Medicine: 5 patents #52 of 907Top 6%
SR Sloan Kettering Institute For Cancer Research: 3 patents #138 of 644Top 25%
TA The Government Of The United States Of America: 2 patents #1 of 38Top 3%
TC The Regents Of The University Of Calif.: 1 patents #5 of 63Top 8%
TS The Salk Institute Of Biological Studies: 1 patents #1 of 21Top 5%
TA The United States Of America: 1 patents #67 of 521Top 15%
NU New York University: 1 patents #708 of 1,640Top 45%
HI Howard Hughes Medical Institute: 1 patents #66 of 128Top 55%
SY Synergen: 1 patents #14 of 32Top 45%
📍 Village of La Jolla, CA: #14 of 2,316 inventorsTop 1%
🗺 California: #1,062 of 386,348 inventorsTop 1%
Overall (All Time): #6,726 of 4,157,543Top 1%
144
Patents All Time

Issued Patents All Time

Showing 76–100 of 144 patents

Patent #TitleCo-InventorsDate
6673587 Histone deacetylase, and uses therefor Hung-Ying Kao, Michael Downes, Peter Ordentlich 2004-01-06
6646008 Treatment of disease states which result from neoplastic cell proliferation using PPAR-&ggr; activators and compositions useful therefor Peter Tontonoz, Laszlo Nagy 2003-11-11
6605627 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof Barry Forman 2003-08-12
6586455 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid X receptor selective agonists Peter Tontonoz, Bruce M. Spiegelman, Barry Forman 2003-07-01
6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor David J. Mangelsdorf, Richard A. Heyman, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2003-06-10
6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor J. Don Chen 2003-04-22
6506917 Compounds and compositions useful for modulation of processes mediated by RXR David J. Mangelsdorf, Richard A. Heyman, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2003-01-14
6492137 Response element compositions and assays employing same Henry M. Sucov, Kazuhiko Umesono 2002-12-10
6489441 Transcriptional co-repressor that interacts with nuclear hormone receptors J. Don Chen 2002-12-03
6458926 Heterodimer complex of RXR and NURR1 or NGFI-B Barry Forman, Kazuhiko Umesono 2002-10-01
6436993 Use of RAR antagonists as modulators of hormone mediated processes Peter Tontonoz, Laszlo Nagy 2002-08-20
6416957 Method for modulating process mediated by farnesoid activated receptors Barry Forman, Cary A. Weinberger 2002-07-09
6413994 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof Barry Forman 2002-07-02
6391847 Method, polypeptides, nucleotide sequence of XOR-6, a vitamin D-like receptor from xenopus Bruce Blumberg, Kazuhiko Umesono 2002-05-21
6387673 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds Laszlo Nagy 2002-05-14
6333318 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto Enrique Saez 2001-12-25
6319663 Method for the identification and use of substances that modulate POD function and/or structure Vassilis Doucas 2001-11-20
6284870 Gamma retinoic acid receptor Fumimaro Takaku, Takashi Ishikawa, Michio Imawari, Kazuhiko Umesono 2001-09-04
6281330 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor Michael B. Mc Keown, Anthony E. Oro, William A. Segraves, Tso-Pang Yao 2001-08-28
6278040 Receptor-deficient mice and cell lines derived therefrom, and uses thereof Henry M. Sucov, Kenneth R. Chien 2001-08-21
6265173 Methods of modulating the expression of genes using ultraspiracle receptor Michael B. Mc Keown, Anthony E. Oro, William A. Segraves, Tso-Pang Yao 2001-07-24
6214850 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof Barry Forman 2001-04-10
6184353 Method for modulating processes mediated by farnesoid activated receptors Barry Forman, Cary A. Weinberger 2001-02-06
6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones Richard A. Heyman, Christina S. Berger, Robert B. Stein 2000-08-01
6022897 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof Barry Forman 2000-02-08